Transmission of tuberculosis to close contacts of patients with multidrug-resistant tuberculosis.
about
Drugs for preventing tuberculosis in people at risk of multiple-drug-resistant pulmonary tuberculosisWeekly rifapentine/isoniazid or daily rifampin/pyrazinamide for latent tuberculosis in household contactsBUILDING NEW KNOWLEDGEDOTS and DOTS-plus: not the only answer.Estimating the extent of household contact misclassification with index cases of disease in longitudinal studies using a stochastic simulation modelMicroscopic observation drug susceptibility assay, a rapid, reliable diagnostic test for multidrug-resistant tuberculosis suitable for use in resource-poor settings.Detection of kanamycin-resistant Mycobacterium tuberculosis by identifying mutations in the 16S rRNA gene.Community based approaches to the control of multidrug resistant tuberculosis: introducing "DOTS-plus".The susceptibility of Mycobacterium tuberculosis to isoniazid and the Arg-->Leu mutation at codon 463 of katG are not associated.Long term follow-up of drug resistant and drug susceptible tuberculosis contacts in a Low incidence setting.Transmission of Mycobacterium tuberculosis to contacts of HIV-infected tuberculosis patients.Adverse events in healthy individuals and MDR-TB contacts treated with anti-tuberculosis drugs potentially effective for preventing development of MDR-TB: a systematic review.Controversies in preventive therapy for children contacts of multidrug-resistant tuberculosis.The use of anti-tuberculosis therapy for latent TB infectionIncidence of TB and HIV in prospectively followed household contacts of TB index patients in South AfricaManagement of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries.Contact investigation for tuberculosis: a systematic review and meta-analysis.Rapid screening of inhibitors of Mycobacterium tuberculosis growth using tetrazolium saltsThe emergence of Beijing family genotypes of Mycobacterium tuberculosis and low-level protection by bacille Calmette-Guérin (BCG) vaccines: is there a link?Detection of a point mutation associated with high-level isoniazid resistance in Mycobacterium tuberculosis by using real-time PCR technology with 3'-minor groove binder-DNA probes.Management of multidrug-resistant tuberculosis: Update 2007.Hospital control and multidrug-resistant pulmonary tuberculosis in female patients, Lima, PeruTuberculosis contact control in Brazil: a literature review (1984-2004).Yield of contact investigations in households of patients with drug-resistant tuberculosis: systematic review and meta-analysisPhenotypic and Genotypic Analysis of Multidrug-Resistant Mycobacterium tuberculosis Isolates from Sudanese Patients.Multi-drug resistant childhood tuberculosis.Dilemma of managing asymptomatic children referred with 'culture-confirmed' drug-resistant tuberculosisSystematic Review, Meta-analysis, and Cost-effectiveness of Treatment of Latent Tuberculosis to Reduce Progression to Multidrug-Resistant Tuberculosis.Preventive therapy for child contacts of multidrug-resistant tuberculosis: a prospective cohort study.Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement.Treating multidrug-resistant tuberculosis in Tomsk, Russia: developing programs that address the linkage between poverty and disease.Tuberculosis in a psychiatric hospital in the state of Goiás, Brazil.Latent tuberculosis infection is associated with increased unstimulated levels of interferon-gamma in Lima, Peru
P2860
Q24246070-26C3B329-44D7-467F-B07F-C7FF55FAC3DFQ24650581-FBFF4B79-E549-4886-8A63-194DA00CCD34Q29248576-D9EEF824-58DC-419B-A62C-2293FEFEBA82Q30329428-D06F4110-7FC3-4E5B-83D7-F679E4462B22Q30394361-EE3A074D-FB38-4D34-A2CE-4386DC17779EQ31119394-9DC2DEE7-EAE4-44A8-95A0-C4DDF57CAF60Q33665452-F5D8DBE0-F80D-4D82-B176-C29519558028Q33791822-5493FFEA-4E4F-4B8F-851A-5F3C6FA979CFQ33972028-71FA4BC3-A9FF-4E78-97D5-1B69F52A608EQ34454109-B0C17596-8019-454B-8408-E3F4D21570EBQ34467350-19136DE3-3B23-4FB9-8C53-185B7A446173Q34551560-DA8115E5-D055-4FA9-97C7-199C3F192619Q35007404-50F99F02-D41A-4111-B334-695E9B0AC82BQ35026573-BC10C05F-6CCC-473F-B821-106A9D9E042FQ35156066-263A658F-CE01-4343-9BAA-50290486D483Q35787450-B8DBB88E-B7FC-4F80-87A7-7CD36D236665Q36498173-39E36F13-E1BC-42F5-A432-1D78D3CF4205Q36561229-F3737DE2-D6E6-458A-A022-1128F7E9979FQ36565187-40C6EFC4-17D1-49A3-992B-3BD3351A1215Q36891764-4F25AF38-0069-43AF-8537-0898F0CFABCEQ37058166-116AD01C-861D-4C2A-B592-DB5EA0B2F72AQ37074695-632FEC1C-A038-4DF4-BF90-1E779EDEB21FQ37174424-8B572A09-591C-4173-B137-864256A39B61Q37473011-0A071E06-E736-4D2D-B998-ED007AE5B392Q37618192-74876A2F-996B-4EAB-979B-F3B45B92F3A7Q37824823-D1F35CD5-DD3B-486E-A4CB-A80E6AB20CB4Q38797948-FEC0BE70-CF39-48C7-B82F-FD792AF6A874Q38886442-672411F5-8913-4C60-929A-778063A7521BQ42246655-BA89EAEC-5AED-4468-BD36-0558A186490BQ42715629-A14D4F12-81E9-4F89-BB3A-DF273EE71917Q45306776-EFA8F5E8-B07B-43A1-9A37-41B7B00A0C6AQ48912702-94346E4D-6430-4368-9ED3-2DEC435FBEF7Q58744448-5370CC2A-186C-4476-887E-6168DF14BFE9
P2860
Transmission of tuberculosis to close contacts of patients with multidrug-resistant tuberculosis.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh-hant
name
Transmission of tuberculosis t ...... tidrug-resistant tuberculosis.
@en
Transmission of tuberculosis t ...... tidrug-resistant tuberculosis.
@nl
type
label
Transmission of tuberculosis t ...... tidrug-resistant tuberculosis.
@en
Transmission of tuberculosis t ...... tidrug-resistant tuberculosis.
@nl
prefLabel
Transmission of tuberculosis t ...... tidrug-resistant tuberculosis.
@en
Transmission of tuberculosis t ...... tidrug-resistant tuberculosis.
@nl
P2093
P1476
Transmission of tuberculosis t ...... ltidrug-resistant tuberculosis
@en
P2093
C E Carvalho
E Werneck-Barroso
G de N Andrade
L M Andrade
M A Vieira
M F Rabahi
M J Marques
P P Gontijo
R Bravo-de-Souza
P304
P356
10.1164/AJRCCM.153.1.8542139
P407
P577
1996-01-01T00:00:00Z